Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Sectors

Whispr negotiates $750,000
DTU-owned PreSeed Ventures joined Bose Ventures in occupational voice guidance technology developer Whispr’s round, which will help the startup double its headcount.
Saarland moulds Mac Panther Materials
Mac Panther Materials will operate as a subsidiary of manufacturing machinery supplier Mac Panther on the back of a spinout agreement with Saarland University.
Wanda and Vortex to vacate stage
Embattled commercialisation firm NetScientific is closing two medical diagnostics spinouts from UCLA after both failed to attract external funding.
Scottish universities sign up to Converge
Converge is now affiliated to all 18 Scottish universities, offering a prize fund of $305,000 through four competition-orientated programs.
CDL reaches Oxford
Toronto's Creative Destruction Lab accelerator network will open its first UK-based location through a partnership with University of Oxford after expanding into the US with NYU in 2018.
NervGen Pharma holds nerve for $7.5m IPO
CWRU-licensed NervGen Pharma floated at the top of its range on the TSX Venture Exchange, with the proceeds earmarked to push its lead candidate for spinal cord injury into the clinic.
Respirion inhales $14.2m
Cystic fibrosis drug developer Respirion Pharmaceuticals has spun out from Telethon Kids Institute with capital from an Australian government-backed initiative.
Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.

News Continued

Gencove adds $3m to funding sequence
New York Genome Center-founded Gencove has added $3m from investors including Alexandria Venture Investments to bring its genomics testing kit to new markets.
Phasecraft executes funding
Based on UCL and Bristol research, Phasecraft is a member of a UK government-backed quantum collaboration driven by both universities together with the Google Quantum AI Lab.
Yunhu delivers series A-plus
The medical research services provider collected funding from investors including Cash Capital, an investment arm of CAS which previously backed a series A.
Sharpen phones IU in $15m round
IU Philanthropic Venture Fund was among the investors in the contact centre platform creator's round, which will help grow the business through recruitment and product development.
Well Doc recuperates with $1.6m
Scotiabank has supplied University of Calgary-affiliated Well Doc Alberta with funding under a pact signed when it bought MD Financial Management last year.
FanFood munches on $2m
The series A round reportedly featured UCLA Ventures, with the cash going towards expanding the business and technology for FanFood’s events concession app.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
test reg

Login